Pharmaceutical Suppositories Market Research, 2032
The global pharmaceutical suppositories market size was valued at $1.6 billion in 2022, and is projected to reach $2.8 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Pharmaceutical suppositories are solid or semi-solid dosage forms that are inserted into various body cavities, primarily the rectum, vagina, or urethra, for the purpose of delivering medication. These suppositories consist of active pharmaceutical ingredients (APIs) combined with a base material that solidifies at or near body temperature. Upon insertion, the suppository dissolves, melts, or disperses, releasing the medication for absorption through the mucous membranes or local tissues.
Suppositories are used when alternative routes of drug administration are less effective, such as when patients have difficulty swallowing pills, experience nausea or vomiting, or require targeted localized drug delivery. They are especially valuable for medications that need to bypass the digestive system or liver metabolism, ensuring more direct and efficient drug absorption.
Market Dynamics
The pharmaceutical suppositories market size is experiencing significant growth driven by several key factors. First and foremost, the expanding population of elderly individuals, often referred to as the geriatric population, is a major catalyst for this growth. As people age, they tend to develop a higher incidence of chronic and acute medical conditions that require targeted and localized drug delivery. Suppositories, with their ability to provide precise dosing and minimize systemic side effects, are particularly well-suited for this demographic. The rising elderly population is thus fueling the demand for pharmaceutical suppositories as an effective means of treatment.
Moreover, the global increase in the prevalence of chronic and acute diseases is contributing to the market's growth. Conditions like inflammatory bowel disease, hemorrhoids, vaginal infections, and pain management often benefit from suppository-based drug delivery. With a growing number of people affected by these health issues, the demand for suppositories is on the rise.
Furthermore, technological advancements in suppository manufacturing and drug formulation are also driving market growth. These advancements enhance the effectiveness, safety, and patient acceptability of suppositories. Improved formulations and innovative delivery systems make suppositories more attractive to both healthcare providers and patients, further boosting pharmaceutical suppositories market growth.
However, the limited drug compatibility, as suppositories are not suitable for all medications due to stability and solubility challenges are some factors that impede growth during the pharmaceutical suppositories market forecast. Furthermore, manufacturing complexities, which demand specialized equipment and processes, elevate production expenses and constrain the number of manufacturers. This restricts market accessibility and affordability, creating barriers to the widespread adoption of suppositories.
A recession can have adverse effects on the pharmaceutical suppositories market in several ways. Economic pressures lead to reductions in healthcare spending by both governments and individuals. During economic downturns, people may postpone seeking medical care or choose more cost-effective treatments, potentially bypassing suppository-based medications. This presents challenges, as decreased healthcare spending and delayed medical decisions can dampen demand for suppositories and create financial obstacles for pharmaceutical companies.
However, the market benefits from key players like Bliss GVS Pharma Ltd and Zydus Lifesciences Limited, actively producing cost-effective generic suppositories. Generic suppositories are often more affordable than branded alternatives, making them attractive to both healthcare providers and patients, especially during economic downturns when cost-efficiency is crucial.
Segmental Overview
The pharmaceutical suppositories market is segmented into type, base, distribution channel, end user, prescription type and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. On the basis of base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, it is classified into hospitals & clinics, home care and nursing home. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Type
The pharmaceutical suppositories market is segmented into rectal suppositories, vaginal suppositories and urethral suppositories. The rectal suppository segment was the largest revenue contributor to the market in 2022. This sustained growth can be credited to its versatility, effectiveness, and its applicability across a wide range of medical conditions. Furthermore, continuous research efforts and endorsements from healthcare professionals play a role in its ongoing expansion.
However, the vaginal suppositories segment is expected to register the fastest growth during the forecasted period. The growth is linked to the rising adoption of gynecological and women's health applications. Vaginal suppositories provide targeted drug delivery for issues like vaginal infections and hormone therapy, ensuring swift and efficient treatment with minimal systemic effects. These advantages are key drivers of market growth in the foreseeable future.
By Base
The pharmaceutical suppositories market is segmented into fatty base, water-miscible bases, and emulsifying bases. The emulsifying bases segment was the highest revenue contributor to the market in 2022 and is expected to remain dominant during the forecasted period. This is attributed to its versatility in formulating various suppository types. Emulsifying bases are ideal for a broad spectrum of drug compatibility and release profiles, making them the top pick for pharmaceutical suppository formulations.
By Distribution Channel
The pharmaceutical suppositories industry is segmented into hospital pharmacies, retail pharmacies, and online sales. The hospital pharmacies segment was the largest revenue contributor to the market in 2022 owing to several factors. The increased use of suppositories in hospitals stems from their ability to deliver drugs precisely to specific areas, reducing the risk of systemic side effects. Hospitals find these suppositories valuable for a wide range of medical conditions and diverse treatment requirements, driving up demand within this healthcare setting.
However, the online sales segment is expected to register the fastest growth during the forecasted period owing to ease and accessibility, online purchasing has become a popular choice for consumers looking to buy healthcare products like suppositories. Online platforms offer a convenient alternative to physical stores, allowing customers to place orders effortlessly. The wider range of available products and the potential for competitive pricing enhance the appeal of online sales as a convenient option for obtaining suppositories and other healthcare items.
By End User
The pharmaceutical suppositories industry is classified into hospitals & clinics, home care and nursing home. the hospital & clinics segment was the largest pharmaceutical suppositories market share holder in 2022. This was attributed to the growing preference of hospitals and clinics for pharmaceutical suppository products. Additionally, an increase in government initiatives aimed at enhancing the treatment of chronic diseases and the proliferation of hospitals adopting suppository therapy have contributed to the expansion of the hospitals and clinics segment.
However, the home care segment is expected to register the fastest growth during the forecasted period owing to several key factors. Patients increasingly prefer home-based healthcare, creating demand for user-friendly drug delivery methods such as suppositories. In addition, the aging population and the trend toward self-administration of medications at home further boost the growth of this segment.
By Prescription Type
The pharmaceutical suppositories market is bifurcated into OTC and prescribed suppositories. The prescribed suppositories segment was the highest revenue contributor to the market in 2022. This is attributed to the rising prevalence of chronic diseases and the demand for precise drug delivery approaches. Additionally, advancements in pharmaceutical formulations and the emergence of precision medicine have paved the way for personalized prescriptions, which in turn, are driving the expansion of the prescribed suppositories segment.
However, the OTC segment is expected to register the fastest growth during the forecasted period. This is primarily due to a growing consumer inclination toward self-care and convenience. OTC products, readily available without a prescription, offer a convenient and cost-effective solution for managing common health issues. This accessibility and ease of use make OTC products increasingly popular, driving their market expansion during the forecasted period.
By Region
The pharmaceutical suppositories market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest pharmaceutical suppositories market share in terms of revenue in 2022 owing to several key factors. The region boasts a well-established and advanced healthcare industry, facilitating the development, production, and distribution of suppository-based medications. North America is also home to several leading pharmaceutical manufacturers, driving innovation and product availability. Furthermore, the high adoption rate of suppositories among healthcare practitioners and patients in North America contributes significantly to its market leadership, making it a pivotal region for pharmaceutical suppositories' revenue growth.
However, the Asia-Pacific region is projected to exhibit the highest CAGR in the pharmaceutical suppositories market during the forecast period. This growth can be attributed to multiple factors, including the rising geriatric population and the increased prevalence of chronic disorders in the region. Furthermore, ongoing enhancements in healthcare infrastructure and a surge in initiatives aimed at raising awareness and facilitating early diagnosis and treatment are anticipated to drive market expansion in the Asia-Pacific. These factors collectively create a favorable environment for the growth of pharmaceutical suppositories in the region.
Furthermore, a rise in research activities as well as the well-established presence of domestic companies in the region are expected to provide notable opportunities for market growth. In addition, a rise in contract manufacturing organizations within the region provides is expected to drive market growth.
Competition Analysis
Competitive analysis and profiles of the major players in the pharmaceutical suppositories market such as Major players that operate in the market include Bayer AG, Bliss Gvs Pharma Ltd, Viatris Inc, Cadila Healthcare Ltd., Church & Dwight Co., Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A. key players have adopted strategy such as product approval to enhance their product portfolio.
Recent Product Approval in the Pharmaceutical Suppositories Market
- In February 2020, Zydus Lifesciences Limited, announced that it has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use, (US RLD - Canasa) 1000 mg. The drug is used to treat ulcerative proctitis, a type of bowel disease.
- In August 2023, Zydus Lifesciences Limited, announced that it has received a USFDA approval to manufacture and market Indomethacin suppositories, 50mg. Indomethacin suppositories, 50 mg is the generic version of the Reference Listed Drug (RLD) Indocin suppositories.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2022 to 2032 to identify the prevailing pharmaceutical suppositories market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.
Pharmaceutical Suppositories Market Report Highlights
| Aspects | Details |
 Market Size By 2032 | USD 2.8 billion |
 Growth Rate | CAGR of 5.7% |
 Forecast period | 2022 - 2032 |
 Report Pages | 377 |
 By Type |
|
 By Base |
|
 By End User |
|
 By Distribution Channel |
|
 By Prescription Type |
|
 By Region |
|
 Key Market Players | Glenmark Pharmaceuticals Limited, Cadila Healthcare Ltd, Intas Pharmaceuticals Ltd., Church & Dwight Co. Inc., Bliss GVS Pharma Ltd, Viatris Inc., Sanofi S.A., Novartis AG, Bayer AG, Pfizer Inc. |
Analyst Review
Parmaceutical suppositories provide great alternative of drug delivery and can be useful in case of unconscious patients or where direct on-site action is desired.
The factors such as increased geriatric population, rise in number of gastro-intestinal diseases across the globe, rise in intra uterine diseases and various chronic diseases and rise in number of hospitals & clinics are expected to drive the growth of the pharmaceutical suppositories market. Moreover, the increase in use of rectal suppositories and technological advancements further boost the growth of the market.
In addition, North America is expected to witness the highest growth, in terms of revenue, owing to ongoing technological advancements, a well-established and advanced healthcare infrastructure, and adoption of suppositories for treatment by patients and healthcare providers. However, Asia-Pacific is anticipated to witness notable growth, owing to a rise in geriatric population and an increase in initiative to expand the healthcare facilities in the region, thus driving the growth of the market during the forecast period.
Pharmaceutical suppositories are dosage forms inserted into body cavities, most commonly the rectum, to deliver drugs to the systemic circulation and local tissues. Suppositories are valuable additions to the symptom control armamentarium, especially for patients unable to take drugs orally due to nausea and vomiting.
The major factor that fuels the growth of the pharmaceutical suppositories market are technological advancements, rise in prevalence of acute and chronic disorders which require the use of suppository and increase in the geriatric population drive the growth of the global pharmaceutical suppositories market .
The base year is 2022 in pharmaceutical suppositories market .
The rectal suppository segment is the most influencing segment in pharmaceutical suppositoroes market.This is attributed to its versatility, efficacy, and the broad spectrum of medical conditions it addresses. In addition, ongoing research and healthcare provider recommendations contribute to its sustained growth.
Top companies such as Bliss GVS Pharma Ltd, Pfizer Inc, Bayer AG and Novartis AG held a high market position in 2022. These key players held a high market postion owing to the strong geographical foothold in North America, Europe, Asia-Pacific, and LAMEA.
The forecast period for pharmaceutical suppositories market is 2023 to 2032
The total market value of pharmaceutical suppositories market is $1.6 billion in 2022.
The market value of pharmaceutical suppositories market in 2032 is $2.8 billion
Loading Table Of Content...
Loading Research Methodology...
